Buzzberg Cup Live

90% of KOSPI trading volume concentrated in 7 stocks… Extreme concentration created by 2x ETFs "Repeated surges and crashes in large-cap stocks" | CEO Lee Ju-hyun

[#UrgentMarketUpdate] 90% of KOSPI trading volume concentrated in 7 stocks… Extreme concentration created by 2x ETFs "Repeated surges and crashes in large-cap stocks" | CEO Lee Ju-hyun
Watch on YouTube ↗  |  July 06, 2026 at 07:30  |  20:26  |  815 Money Talk (815머니톡)
Speakers
Lee Ju-hyeon — Director, Xangle

Summary

KOSPI is in a downtrend with 90% of trading volume concentrated in seven AI-related large-cap stocks due to leveraged ETFs. CEO Lee Ju-hyun advises focusing on Samsung Electronics and SK hynix, buying on dips with dollar-cost averaging, while raising cash. Securities stocks benefit from surging brokerage commissions, and bank stocks reflect global rate hikes. Korean biotech remains weak and should be avoided until a clear uptrend emerges.

  • 90% of KOSPI trading volume is concentrated in seven AI-related large-cap stocks driven by 2x ETF products.
  • Lee Ju-hyun recommends buying Samsung Electronics and SK hynix on dips using dollar-cost averaging.
  • Securities stocks such as NH Investment & Securities are strong on exploding ETF-driven trading commissions and solid Q2 earnings expectations.
  • Bank stocks are supported by global rate hike trends and improving margins, mirroring US bank strength.
  • Korean healthcare/biotech is not following the US healthcare rally; it remains vulnerable and should be avoided until a clear uptrend is established.
  • Construction stocks show only short-term thematic rotation and are not a sustainable investment opportunity.
  • Market volatility remains elevated, and cash positions should be increased to manage risk.
Ideas
Lee Ju-hyeon Director, Xangle 4:03
Buy Samsung, SK hynix on dips
AI chip demand will continue to increase as AI becomes more widely used, and extreme concentration of KOSPI trading volume in Samsung Electronics and SK hynix (due to leveraged ETFs) will keep liquidity focused on these leaders. Therefore, buying these two stocks on dips through dollar-cost averaging is the right approach to make money in the current market.
Lee Ju-hyeon Director, Xangle 13:11
Korean securities benefit from volume surge
Exploding trading volumes from leveraged ETFs have caused brokerage commissions to surge, and the upcoming Q2 earnings season is expected to confirm strong performance; securities stocks are rising on this earnings tailwind despite negative headlines at individual firms.
Lee Ju-hyeon Director, Xangle 15:01
Korean banks rise on rate hikes
Global rate hikes (e.g., Europe, Japan) and strong US bank stocks suggest improving net interest margins; Korean banks are reflecting this positive flow and are holding up relatively well in a weak market.
Lee Ju-hyeon Director, Xangle 19:42
Avoid Korean biotech until uptrend
Korean biotech/healthcare stocks behave as growth names dependent on future expectations, not as defensives. They lack stable cash flows and profit-making ability, and when the broader market weakens they collapse because liquidity has already been drained by AI leaders. Investors should avoid the sector until a clear sustained uptrend is established.
Up Next

This 815 Money Talk (815머니톡) video, published July 06, 2026, features Lee Ju-hyeon discussing 005930.KS, 000660.KS, Korean Securities Sector, 005940.KS, KBE, Korean healthcare/biotech sector. 4 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Lee Ju-hyeon  · Tickers: 005930.KS, 000660.KS, Korean Securities Sector, 005940.KS, KBE, Korean healthcare/biotech sector